CNE/CPE Programs

CNE Activities
Management of Newly Diagnosed, Non-transplant Eligible, Elderly and Relapsed/Refractory Multiple Myeloma Patients: A Two-Part Grand Rounds Series

This two-part grand rounds series focuses on approaches to tailoring induction and maintenance therapy for newly diagnosed, elderly (non-transplant eligible) multiple myeloma patients as well as   treatment and management strategies for relapsed and refractory multiple myeloma.

Diagnosis, Assessment and Management of the Transplant-eligible Multiple Myeloma Patient: A Two-Part Grand Rounds Series

This two-part grand rounds series discusses the essentials for diagnosis, staging, risk stratification, prognosis, and response assessment of the multiple myeloma patient; and the approaches to tailoring primary therapy for newly diagnosed, transplant-eligible multiple myeloma patients in addition to anticipated therapy-induced side effects.

Managing Oncologic Emergencies: Renal Failure, Hypercalcemia and Venous Thromboembolism in the Multiple Myeloma Patient

Kimberly Noonan, MS, RN, ANP, AOCN, invites you to join her as she discusses the diagnosis, treatment, and risk-reduction of three common medical emergencies encountered in multiple myeloma patients: hypercalcemia, renal failure, and venous thromboembolism.

CPE Activities
Multiple Myeloma Relapsed/Refractory Disease Management Multiple Myeloma Relapsed/Refractory Disease Management

Join Dr. David Siegel in a grand rounds discussion regarding the treatment and management strategies for relapsed and refractory multiple myeloma.

Newly Diagnosed, Elderly, Non-transplant Eligible Patient Newly Diagnosed, Elderly, Non-transplant Eligible Patient

Dr. Adam Cohen invites you to join him in a grand rounds discussion regarding approaches to tailoring induction and maintenance therapy for newly diagnosed, elderly (non-transplant eligible) multiple myeloma patients.

Newly Diagnosed, Transplant Eligible Patient Newly Diagnosed, Transplant Eligible Patient

Dr. Edward Stadtmauer invites you to join him in a grand rounds discussion regarding approaches to tailoring induction therapy for newly diagnosed, transplant eligible multiple myeloma patients.

Diagnosis, Staging, Risk Stratification, Prognosis and Response Assessment for the Newly Diagnosed MM Patient Diagnosis, Staging, Risk Stratification, Prognosis and Response Assessment for the Newly Diagnosed MM Patient

Dr. G. David Roodman invites you to join him in discussions of a "real-world" newly diagnosed MM patient. The case focuses on clinical features, required diagnostic work-up, patient staging, and risk-stratification. It also addresses common comorbidities including treatment prioritization, goals, and patient response assessment according to International Myeloma Working Group (IMWG) universal response criteria.